Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Thursday . The stock traded as high as $11.47 and last traded at $11.00, with a volume of 650688 shares. The stock had previously closed at $10.50.
Cybin Price Performance
The stock has a market cap of $1.72 billion and a price-to-earnings ratio of -48.33. The stock’s 50-day moving average is $8.29 and its 200-day moving average is $3.07.
Cybin Company Profile
Cybin Inc, a life sciences company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products.
Further Reading
- Five stocks we like better than Cybin
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How to Evaluate a Stock Before Buying
- Time to Load Up on Home Builders?
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
